Category: plos

PLoS ONE issues expression of concern when company won’t share bacterial strain

plosoneThe editors of PLoS ONE have issued an expression of concern for a 2014 article on a form of nitrogen-fixing bacteria called Bacillus pumilus.

The reason: The company that provided the strain of microbe used in the research won’t let other researchers look at the organism.

The article is titled “Bacillus pumilus Reveals a Remarkably High Resistance to Hydrogen Peroxide Provoked Oxidative Stress,” and it came from a group led by Stefan Handtke, of the University of Greifswald, in Germany.

Here’s the notice: Continue reading PLoS ONE issues expression of concern when company won’t share bacterial strain

Three PLOS ONE papers retracted for totally made-up data

This one comes to us from Twitter, where Willem van Schaik went to express his frustration that a PLOS ONE paper he’d edited had been retracted for fake data.

Two other papers from the same group at the Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Chandigarh, India, were retracted simultaneously.

We sent van Schaik an email to get a clearer picture of the situation. He responded: Continue reading Three PLOS ONE papers retracted for totally made-up data

Wayward “contractor” prompts expression of concern for PLoS ONE paper on cancer cells

logoThe editors of PLoS ONE have issued an Expression of Concern (which seems likely to become a retraction) for a 2014 paper by a group of researchers in China who claim to have been led astray by a contractor hired to “edit the language” of the report.

The article, “Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein,” came from a group in the Department of Hematology at the First Affiliated Hospital at Xi’an Jiaotong University, and was led by Yuwang Tian, a pathologist at the General Hospital of Beijing Military Area of PLA.

Or at least that’s what the manuscript eventually said. According to the expression of concern, however, that’s not what it said initially: Continue reading Wayward “contractor” prompts expression of concern for PLoS ONE paper on cancer cells

Wrong cell line leads to retraction of kidney cancer study

plosoneA group of authors in China has retracted their December 2013 paper in PLoS ONE after realizing that they’d been studying the wrong cells.

The paper, “Up-Regulation of pVHL along with Down-Regulation of HIF-1α by NDRG2 Expression Attenuates Proliferation and Invasion in Renal Cancer Cells,” came from Lei Gao, of the Fourth Military Medical University, in Xi’an, and colleagues. It purported to find that:

Continue reading Wrong cell line leads to retraction of kidney cancer study

Following criticism, PLOS apologizes, clarifies new data policy

plosIn response to “an extraordinary outpouring of discussions on open data and its place in scientific publishing” following a February 24 announcement about a new data policy at PLOS, the publisher has apologized and corrected the record.

The new policy — which was actually first announced on January 23, as we noted here — had led to criticism at the DrugMonkey blog, and a February 26 clarification seemed to do little to convince another critic. (Not all disagreed with the policy, however.)

In particular, there were objections to a section that began with Continue reading Following criticism, PLOS apologizes, clarifies new data policy

PLOS Blogs removes post criticizing writer over sexual harassment post

plos blogsTabitha Powledge and Beryl Benderly, two long-time science writers, have found a post they wrote on PLOS Blogs taken down. The removal follows an online dispute with another blogger, Emily Willingham, about the post, which covered a session on sexual harassment, The XX Question, at the recent National Association of Science Writers (NASW) meeting in Florida.

Willingham had objected to a roundup of the session by Powledge and Benderly, pointing to, among other things, what she considered to be a white-washing of the problem and a rather hegemonic reflection of the issue which trivialized the plight of women in the field and glorified the role of a few righteous XYs.
Continue reading PLOS Blogs removes post criticizing writer over sexual harassment post

Chutzpah: Authors blame PLOS ONE for failing to find plagiarism in paper on Botulinum toxin

plosonelogoHoly Chutzpah, Batman! A team of researchers in India has retracted their 2012 paper in PLoS One on botulinum toxin for plagiarism — while blaming the journal for failing to use its “soft wares” to catch the plagiarism.

The article, “Small-Molecule Quinolinol Inhibitor Identified Provides Protection against BoNT/A in Mice,” was written by a group from the Defence Research and Development Establishment, in Madhya Pradesh.

According to the retraction notice: Continue reading Chutzpah: Authors blame PLOS ONE for failing to find plagiarism in paper on Botulinum toxin

Doing the right thing: Researchers retract quorum sensing paper after public process

Pamela Ronald, via UC Davis
Pamela Ronald, via UC Davis

We’ll say it again: We like being able to point out when researchers stand up and do the right thing, even at personal cost.

In December 2011, Pamela C. Ronald, of the University of California, Davis, and colleagues published a paper in PLOS ONE,”Small Protein-Mediated Quorum Sensing in a Gram-Negative Bacterium.” Such quorum sensing research is a “hot topic” right now, so not surprisingly the paper caught the attention of other scientists, and the media, including the Western Farm Press. The study has been cited eight times, according to Thomson Scientific’s Web of Knowledge.

One of those scientists who took notice was Ronald’s UC Davis colleague Jonathan Eisen, who posted about the paper on his blog. That was on January 9, 2012. But if you go to that post today, you’ll see that Eisen struck through most of it, and added this comment: Continue reading Doing the right thing: Researchers retract quorum sensing paper after public process

Birds of a feather: Authors who play games with fowl data earn multiple retractions

jmicrobiotechA group of animal health researchers from the Chinese Academy of Agricultural Sciences have lost their 2009 paper in the Journal of Microbiology and Biotechnology because they’d published the data in at least four other articles.

The paper, “Two Novel Duck Antibacterial Peptides, Avian β-Defensins 9 and 10, with Antimicrobial Activity,” reported that: Continue reading Birds of a feather: Authors who play games with fowl data earn multiple retractions

A mega-correction for Rui Curi, whose lawyers threatened to sue Science-Fraud.org

plos oneA Brazilian researcher whose legal threats helped lead to the shutdown of Science-Fraud.org and who has had two papers retracted has had to correct another paper.

The fourth correction for Rui Curi — and we’d call it a mega-correction — is of a paper in PLOS ONE. Curi is the fourth out of 11 authors; someone named Tania Pithon-Curi is the final author:
Continue reading A mega-correction for Rui Curi, whose lawyers threatened to sue Science-Fraud.org